[go: up one dir, main page]

TW200500368A - Process to tetrahydrotriazolopyrazines and intermediates - Google Patents

Process to tetrahydrotriazolopyrazines and intermediates

Info

Publication number
TW200500368A
TW200500368A TW093105894A TW93105894A TW200500368A TW 200500368 A TW200500368 A TW 200500368A TW 093105894 A TW093105894 A TW 093105894A TW 93105894 A TW93105894 A TW 93105894A TW 200500368 A TW200500368 A TW 200500368A
Authority
TW
Taiwan
Prior art keywords
tetrahydrotriazolopyrazines
intermediates
useful
pyrazines
triazolo
Prior art date
Application number
TW093105894A
Other languages
English (en)
Chinese (zh)
Inventor
Jaume Balsells
Jin-Chu Liu
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of TW200500368A publication Critical patent/TW200500368A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW093105894A 2003-03-07 2004-03-05 Process to tetrahydrotriazolopyrazines and intermediates TW200500368A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45274803P 2003-03-07 2003-03-07

Publications (1)

Publication Number Publication Date
TW200500368A true TW200500368A (en) 2005-01-01

Family

ID=32990678

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093105894A TW200500368A (en) 2003-03-07 2004-03-05 Process to tetrahydrotriazolopyrazines and intermediates

Country Status (3)

Country Link
AR (1) AR043443A1 (fr)
TW (1) TW200500368A (fr)
WO (1) WO2004080958A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2296979T3 (es) 2001-06-27 2008-05-01 Smithkline Beecham Corporation Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
KR20050122220A (ko) 2003-03-25 2005-12-28 다케다 샌디에고, 인코포레이티드 디펩티딜 펩티다제 억제제
EP1625122A1 (fr) 2003-05-14 2006-02-15 Takeda San Diego, Inc. Inhibiteurs de dipeptidyl peptidase
KR20060041309A (ko) 2003-08-13 2006-05-11 다케다 야쿠힌 고교 가부시키가이샤 4-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
EP1794120B1 (fr) 2004-07-23 2012-04-11 Nuada, LLC Inhibiteurs de peptidase
PT1942898E (pt) 2005-09-14 2011-12-20 Takeda Pharmaceutical Inibidores da dipeptidilpeptidase para o tratamento da diabetes
CN101360723A (zh) 2005-09-16 2009-02-04 武田药品工业株式会社 制备嘧啶二酮衍生物的方法
WO2007112347A1 (fr) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Inhibiteurs de la dipeptidyl peptidase
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US10065960B2 (en) 2010-04-02 2018-09-04 Ogeda Sa NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders
SMT201700282T1 (it) 2010-04-02 2017-07-18 Ogeda Sa Nuovi composti antagonisti selettivi del recetiore nk-3, composizione farmaceutica e metodi per l'uso in disturbi mediati dai recettori nk-3
CN102372716A (zh) 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
CN101973997B (zh) * 2010-09-30 2012-06-06 浙江大学 一种磷酸西他列汀侧链的制备方法
CA2840814A1 (fr) 2011-06-29 2013-01-03 Ranbaxy Laboratories Limited Dispersions solides de sitagliptine et leurs procedes de preparation
EP2726483A1 (fr) 2011-06-30 2014-05-07 Ranbaxy Laboratories Limited Nouveaux sels de sitagliptine
SI2763992T1 (sl) 2011-10-03 2016-08-31 Euroscreen S.A. Novi kiralni n-acil-5,6,7,(8-substituirani)-tetrahidro-(1,2,4)triazolo (4,3-a)pirazini kot selektivni nk-3 receptor antagonisti, farmacevtski sestavek, in postopki za uporabo v nk-3 posredovanih motnjah
WO2013084210A1 (fr) 2011-12-08 2013-06-13 Ranbaxy Laboratories Limited Forme amorphe de sels de sitagliptine
EP3197876B1 (fr) 2014-09-25 2018-11-28 Ogeda Sa Nouvelle synthèse chirale de n-acyl-(3-substituées)-(8-substituées)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines
EP3159343B1 (fr) 2015-10-22 2017-07-19 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Procédé amélioré pour la préparation de triazole et de son sel
US10047094B1 (en) 2017-02-10 2018-08-14 F.I.S.—Fabbrica Italiana Sintetici S.p.A. Process for the preparation of triazole and salt thereof
ES2733477T3 (es) 2017-07-04 2019-11-29 Fis Fabbrica Italiana Sintetici Spa Procedimiento eficaz para la preparación de sitagliptina a través de una preparación muy eficaz del intermedio ácido 2,4,5-trifluorofenilacético
KR20200108021A (ko) * 2018-01-09 2020-09-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 Parp 억제제 및 이의 중간체의 제조 방법
ES2770143T3 (es) 2018-02-13 2020-06-30 Fis Fabbrica Italiana Sintetici Spa Nuevo procedimiento eficiente para la preparación de sitagliptina

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 3環性トリアゾロ誘導体の製造方法
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
MY139563A (en) * 2002-09-04 2009-10-30 Bristol Myers Squibb Co Heterocyclic aromatic compounds useful as growth hormone secretagogues

Also Published As

Publication number Publication date
WO2004080958A2 (fr) 2004-09-23
AR043443A1 (es) 2005-07-27
WO2004080958A3 (fr) 2004-12-23

Similar Documents

Publication Publication Date Title
TW200500368A (en) Process to tetrahydrotriazolopyrazines and intermediates
PL392725A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
IL173802A0 (en) Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
DE60223920D1 (en) Pyrrolidine als dipeptidyl peptidase inhibitoren
WO2003002553A3 (fr) Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase
EA201001167A1 (ru) 8-[-3-аминопиперидин-1-ил]ксантины, способ их получения и их применение в качестве лекарственных средств
WO2002098865A3 (fr) Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
MXPA03011907A (es) Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
WO2004085661A3 (fr) Procede de synthese de derives d'acides amines beta chiraux
MXPA05009068A (es) Dihidro-pteridinonas, metodo para la produccion y uso del mismo en la forma de farmacos.
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
TW200512191A (en) Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof
WO2004087650A3 (fr) Procede et intermediaires pour la preparation d'inhibiteurs d'amide d'acide beta-amino de dipeptidyle peptidase-iv
TW200519105A (en) Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
TNSN07244A1 (en) Dipeptidyl peptidase-iv inhibitors
WO2004041258A3 (fr) Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
TW200505923A (en) Process to beta-ketoamide intermediates to dipeptidyl peptidase inhibitors
TW200621716A (en) Novel compounds
AU2003272072A8 (en) A process to prepare pioglitazone via several intermediates.
TW200611701A (en) Novel compounds
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
MXPA05008525A (es) Oxatiincarboxamidas.
UA84172C2 (en) N-substituted pyrazolyl carboxanilides
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers